Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study
Clinical trial NCT00526071 · TERMINATED
Trial details
- NCT number
- NCT00526071
- Sponsor
- Amicus Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-17
- Primary completion
- 2012-09-08
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.